Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TORC

resTORbio (TORC) Stock Price, News & Analysis

resTORbio logo

About resTORbio Stock (NASDAQ:TORC)

Advanced Chart

Key Stats

Today's Range
$0.58
$0.62
50-Day Range
$2.28
$14.77
52-Week Range
$0.86
$10.50
Volume
545,982 shs
Average Volume
1.15 million shs
Market Capitalization
$22.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TORC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for resTORbio and its competitors with MarketBeat's FREE daily newsletter.

TORC Stock News Headlines

Adicet Bio Inc (ACET)
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
TinOne Resources Inc. (TORC.V)
See More Headlines

TORC Stock Analysis - Frequently Asked Questions

resTORbio, Inc. (NASDAQ:TORC) issued its earnings results on Thursday, July, 30th. The company reported ($0.15) earnings per share for the quarter, topping analysts' consensus estimates of ($0.22) by $0.07.

resTORbio (TORC) raised $86 million in an initial public offering (IPO) on Friday, January 26th 2018. The company issued 5,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Leerink Partners and Evercore ISI acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that resTORbio investors own include Novavax (NVAX), VBI Vaccines (VBIV), AbbVie (ABBV), Dynavax Technologies (DVAX), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
7/30/2020
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TORC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.74 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.24 per share
Price / Book
0.27

Miscellaneous

Free Float
N/A
Market Cap
$22.13 million
Optionable
Not Optionable
Beta
2.43
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:TORC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners